Guyana vs Portugal: Tuberculosis patients who tested positive for HIV
Guyana
65 patients
in 2021
Portugal
86 patients
in 2021
Guyana rank
91st
Portugal rank
89th
Tuberculosis patients who tested positive for HIV over time
- Guyana
- Portugal
How they compare
Portugal currently reports 86 patients against 65 patients in Guyana, a difference of 21 patients.
That makes Portugal's figure about 1.3 times Guyana's.
Across all 18 years both countries report, Portugal has been ahead every year.
Guyana ranks 91st and Portugal ranks 89th of 201 countries.
Portugal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guyana | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 121 patients | 501 patients | 380 patients | Portugal |
| 2010s | 156.4 patients | 216.7 patients | 60.3 patients | Portugal |
| 2020s | 54.5 patients | 90.5 patients | 36 patients | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients who tested positive for hiv, Guyana or Portugal?
- Portugal, at 86 patients against 65 patients in Guyana as of 2021.
- What is the difference in tuberculosis patients who tested positive for hiv between Guyana and Portugal?
- 21 patients, with Portugal ahead.
- How many years of comparable data are there for Guyana and Portugal?
- 18 years are reported by both, from 2004 to 2021.
- How do Guyana and Portugal rank globally for tuberculosis patients who tested positive for hiv?
- Guyana ranks 91st and Portugal ranks 89th of 201 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients who tested positive for HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of tuberculosis (new and relapsed) patients that tested positive for HIV.